Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +2.12K | +4.47% | $0.00 | 49.5K | Feb 14, 2024 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$63.6K | -965 | -1.95% | $65.95 | 48.5K | Feb 14, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -2.12K | -25% | $0.00 | 6.35K | Feb 14, 2024 | Common Stock | 2.12K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant. |